Magnetic resonance spectroscopy imaging‐directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate‐specific antigen between 4–10 ng/mL and normal digital rectal examination

International Journal of Urology - Tập 21 Số 3 - Trang 257-262 - 2014
Tarun Javali1, Durgesh K. Dwivedi2, Rajeev Kumar1, N. R. Jagannathan2, Sanjay Thulkar3, Amit K. Dinda4
1Department of Urology, All India Institute of Medical Sciences, New Delhi, India
2Department of NMR & MRI Facility All India Institute of Medical Sciences New Delhi India
3Department of Radio Diagnosis, All India Institute of Medical Sciences, New Delhi, India
4Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

Tóm tắt

ObjectivesTo evaluate the ability of magnetic resonance spectroscopic imaging to improve prostate cancer detection rate.MethodsA retrospective analysis was carried out of 278 men with prostate‐specific antigen in the range of 4–10 ng/mL and normal digital rectal examination who underwent transrectal ultrasound‐guided prostate biopsy. Outcomes were compared between men who had a standard biopsy versus those who also underwent a prebiopsy magnetic resonance spectroscopic imaging. Men with an abnormal voxel on magnetic resonance spectroscopic imaging had standard transrectal ultrasound biopsies plus biopsies directed to the abnormal voxels.ResultsThe study group (n = 140) and control group (n = 138) were similar in baseline parameters, such as mean age, prostate size and mean prostate‐specific antigen. The overall cancer detection in the magnetic resonance spectroscopic imaging positive group (24.4%) was more than double that of the control group (10.1%). On comparing the magnetic resonance spectroscopic imaging results with the transrectal ultrasound biopsy findings, magnetic resonance spectroscopic imaging had 95.6% sensitivity, 41.9% specificity, a positive predictive value of 24.4%, a negative predictive value of 98% and an accuracy of 51.4%.ConclusionsMagnetic resonance spectroscopic imaging‐directed transrectal ultrasound biopsy increases the cancer detection rate compared with standard transrectal ultrasound biopsy in patients with normal digital rectal examination and elevated prostate‐specific antigen in the range of 4–10 ng/mL.

Từ khóa


Tài liệu tham khảo

American Urological Association Education and Research Inc.Prostate‐specific antigen (PSA) best practice statement: 2009 update. [Cited 14 Aug 2013.] Available from URL:http://www.auanet.org/education/guidelines/prostate‐specific‐antigen.cfm

10.1016/j.ucl.2004.01.002

10.1002/nbm.1083

10.1016/S0022-5347(17)38664-0

10.5489/cuaj.800

10.1016/j.eururo.2007.08.006

10.1016/S0022-5347(05)67370-3

10.1002/mrm.10614

10.1007/s10334-008-0122-6

10.2214/ajr.183.4.1831079

10.1006/jmra.1996.0242

10.1002/jmri.21898

10.1016/j.urology.2008.01.014

Agarwal MS, 2004, Measurement of serum PSA in benign and malignant enlargements of prostate in Indian population: relevance of PSAD in Intermediate range PSA, Ind. J. Urol., 20, 138, 10.4103/0970-1591.21530

10.4103/0970-1591.32060

Scher HI, 2000, Clinical Oncology, 1823

10.4103/0970-1591.98487

10.1148/radiology.198.3.8628874

10.1016/S0022-5347(05)67995-5

10.1159/000283071

10.1016/S0022-5347(05)67993-1

10.1016/S0022-5347(05)66083-1

Kumar V, 2006, 3D 1H MRSI based TRUS guided biopsies in men with suspected prostate cancer, Proc. Intl. Soc. Mag. Reson. Med., 14, 1790

10.1118/1.1806292

10.1111/j.1464-410X.2007.07348.x

10.1111/j.1464-410X.2011.10112.x

10.1007/s00330-008-1153-0

10.1002/pros.20859

10.3109/02841850903216718

10.1002/nbm.1522

10.1016/j.eururo.2011.03.002

10.1148/radiol.10091147

10.1016/j.suronc.2009.02.002

10.1002/cncr.23373

10.1148/radiol.12120041

10.1038/nrclinonc.2009.18

10.1111/j.1442-2042.2012.02995.x

Thông tin
Thông tin xuất bản

International Journal of Urology

Tập 21 Số 3

257-262

Thông tin tác giả